ATE124997T1 - Enzymatische entfernung einer aminoterminalen proteinsequenz. - Google Patents

Enzymatische entfernung einer aminoterminalen proteinsequenz.

Info

Publication number
ATE124997T1
ATE124997T1 AT90304890T AT90304890T ATE124997T1 AT E124997 T1 ATE124997 T1 AT E124997T1 AT 90304890 T AT90304890 T AT 90304890T AT 90304890 T AT90304890 T AT 90304890T AT E124997 T1 ATE124997 T1 AT E124997T1
Authority
AT
Austria
Prior art keywords
protein sequence
compounds
enzymatic removal
protein
human insulin
Prior art date
Application number
AT90304890T
Other languages
English (en)
Inventor
Gerald Wayne Becker
Thomas Charles Furman
Warren C Mackellar
James Patrick Mcdonough
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE124997T1 publication Critical patent/ATE124997T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT90304890T 1989-05-09 1990-05-04 Enzymatische entfernung einer aminoterminalen proteinsequenz. ATE124997T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,472 US5126249A (en) 1989-05-09 1989-05-09 Enzymatic removal of a protein amino-terminal sequence

Publications (1)

Publication Number Publication Date
ATE124997T1 true ATE124997T1 (de) 1995-07-15

Family

ID=23372543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90304890T ATE124997T1 (de) 1989-05-09 1990-05-04 Enzymatische entfernung einer aminoterminalen proteinsequenz.

Country Status (12)

Country Link
US (2) US5126249A (de)
EP (1) EP0397420B1 (de)
JP (1) JP2592981B2 (de)
AT (1) ATE124997T1 (de)
AU (1) AU630951B2 (de)
CA (1) CA2016049A1 (de)
DE (1) DE69020794T2 (de)
DK (1) DK0397420T3 (de)
ES (1) ES2075155T3 (de)
HU (1) HU215582B (de)
IE (1) IE67531B1 (de)
IL (1) IL94305A (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93282A (en) * 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
IL104086A (en) * 1991-12-18 1998-03-10 Lilly Co Eli Translational activating oligonucleotide sequence useful for the high level expression of polypeptides and a method for producing such polypeptides
CA2089541A1 (en) * 1992-02-18 1993-08-19 Bruce H. Frank Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
TW257792B (de) * 1992-10-01 1995-09-21 Lilly Co Eli
JP2887060B2 (ja) * 1993-06-30 1999-04-26 日清製粉株式会社 グリセンチンの生産方法
US5573923A (en) * 1993-12-22 1996-11-12 Eli Lilly And Company Method for removing N-terminal dipeptides from precursor polypeptides with immobilized dipeptidylaminopeptidase from dictyostelium discoideum
JP2887063B2 (ja) * 1993-12-28 1999-04-26 日清製粉株式会社 グリセンチンの製造方法
WO1995030685A1 (en) * 1994-05-09 1995-11-16 Unizyme Laboratories A/S An enzymatic process for producing a desired protein from an amino terminal extended protein
ATE350053T1 (de) * 1994-12-29 2007-01-15 Ferring Int Ct Sa Herstellung von humaninsulin
US5840517A (en) * 1995-04-26 1998-11-24 Eli Lilly And Company Process for preparing obesity protein analogs
US5614379A (en) * 1995-04-26 1997-03-25 Eli Lilly And Company Process for preparing anti-obesity protein
CA2253830A1 (en) * 1996-05-08 1997-11-13 Eli Lilly And Company Bovine dipeptidylaminopeptidase 1
AU3640397A (en) * 1996-06-07 1998-01-05 Eli Lilly And Company Ob protein binding protein
DE19943177C2 (de) * 1999-09-09 2002-10-24 Dieter Jenne Verfahren zur Herstellung von aktiven Serienproteasen und inaktiven Varianten
IL141647A0 (en) * 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
DK1404829T3 (da) * 2001-07-06 2008-03-25 Lg Life Sciences Ltd Hidtil ukendt aminopeptidase afledt af bacillus licheniformis, gen der koder for aminopeptidasen, ekspressionsvektor indeholdende genet, transformant og fremgangsmåde til fremstilling deraf
ATE512674T1 (de) * 2003-01-06 2011-07-15 Angiochem Inc Angiopep-1, verwandte verbindungen, und deren verwnedungen
DK1594434T3 (da) * 2003-01-14 2017-01-02 Yeda Res & Dev Company Ltd At The Weizmann Inst Of Science Parenterale formuleringer af peptide til behandling af systemisk lupus erythematosus
NZ541659A (en) 2003-01-14 2007-05-31 Teva Pharma Pharmaceutical composition comprising with a pH between 4 and 9 to treat SLE comprising an aqueous carrier, a pharmaceutically acceptable salt of a peptide and a substituted beta-cyclodextrin
US8618054B2 (en) * 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
EP1751175B1 (de) 2004-05-05 2012-07-25 VALORISATION-RECHERCHE, Société en Commandite Antagonisten des interleukin-1-rezeptors, zusammensetzungen und behandlungsverfahren
AU2006264567A1 (en) 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Cytokine receptor modulators and uses thereof
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CA2688344C (en) 2007-05-29 2019-09-03 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN102026667B (zh) 2008-04-18 2014-06-25 安吉奥开米公司 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
US8828925B2 (en) 2008-10-15 2014-09-09 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
WO2010063122A1 (en) 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
EP2373789A4 (de) 2008-12-17 2012-08-29 Angiochem Inc Membrantyp-1-matrixmetalloproteinase-inhibitoren und ihre verwendung
RU2011146654A (ru) 2009-04-20 2013-05-27 Ангиокем Инк. Способы лечения рака яичников с применением конъюгированного средства
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
EP2588490B1 (de) 2010-07-02 2017-02-22 Angiochem Inc. Kurze und d-aminosäure-haltige polypeptide für therapeutische konjugate und ihre verwendungen
MX360420B (es) * 2012-12-19 2018-10-31 Wockhardt Ltd Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
US11326255B2 (en) 2013-02-07 2022-05-10 Uchicago Argonne, Llc ALD reactor for coating porous substrates
EP3307326B9 (de) 2015-06-15 2021-02-24 Angiochem Inc. Verfahren zur behandlung von leptomeningealer karzinomatose
US11111578B1 (en) 2020-02-13 2021-09-07 Uchicago Argonne, Llc Atomic layer deposition of fluoride thin films
US12065738B2 (en) 2021-10-22 2024-08-20 Uchicago Argonne, Llc Method of making thin films of sodium fluorides and their derivatives by ALD
US11901169B2 (en) 2022-02-14 2024-02-13 Uchicago Argonne, Llc Barrier coatings

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
ATE251217T1 (de) * 1984-08-16 2003-10-15 Savient Pharmaceuticals Inc Methode zur herstellung von menschlichen wachstumshormonen
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
US4865974A (en) * 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
PT83613B (en) * 1985-10-28 1988-11-21 Lilly Co Eli Process for the selective chemical removal of a protein amino-terminal residue
IL91771A0 (en) * 1988-09-30 1990-06-10 Lilly Co Eli Increased expression of small molecular weight recombinant proteins
HUT56857A (en) * 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
IL93282A (en) * 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues

Also Published As

Publication number Publication date
DK0397420T3 (da) 1995-08-21
AU5483390A (en) 1990-11-15
ES2075155T3 (es) 1995-10-01
DE69020794D1 (de) 1995-08-17
US5352769A (en) 1994-10-04
IL94305A0 (en) 1991-03-10
US5126249A (en) 1992-06-30
AU630951B2 (en) 1992-11-12
JP2592981B2 (ja) 1997-03-19
IE901673L (en) 1990-11-09
IE67531B1 (en) 1996-04-03
HUT54213A (en) 1991-01-28
DE69020794T2 (de) 1995-12-14
HU902697D0 (en) 1990-09-28
EP0397420B1 (de) 1995-07-12
CA2016049A1 (en) 1990-11-09
IL94305A (en) 1995-12-08
JPH0334995A (ja) 1991-02-14
HU215582B (hu) 1999-01-28
EP0397420A1 (de) 1990-11-14

Similar Documents

Publication Publication Date Title
AU630951B2 (en) Enzymatic removal of a protein amino-terminal sequence
KR100261030B1 (en) N-terminally chemically modified protein compositions and methods
AU595290B2 (en) Process for producing human epidermal growth factor and analogs thereof
IT1214505B (it) Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
AU5249786A (en) Wound healing compositions
DK485788D0 (da) Kosmetisk praeparat
DE68918246D1 (de) Verbindungen zur Verhinderung von Thrombose.
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DE3852935D1 (de) Substituierte Alpha-Aminosäuren mit pharmazeutischer Aktivität.
EP0587571A4 (de) Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen.
ES539382A0 (es) Procedimiento para la determinacion de fibrina
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DE58908857D1 (de) Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
DE69427148D1 (de) Verfahren zur Herstellung von 2,4,5-Tribrompyrrol-3-carbonitril
DE3887854D1 (de) Verfahren zur Herstellung von Dipeptiden.
ATE147268T1 (de) Hypoglycemische peptide
FI956247A0 (fi) Uusia menetelmiä (S)-4-amino-hepta-5,6-dieenihappo ja sen välituotteiden valmistamiseksi
AU2046888A (en) Process for the preparation of n6-benzyloxycarbonyl-2,6- diaminopimelamic acid in the l, l or d, d or racemic forms
PT84743B (de) Verfahren zur herstellung von l-aminosaueren durch transaminierung
ATE76081T1 (de) Verfahren zur herstellung von dipeptiden mit nterminalen nichtproteinogenen aminosaeuren.
ATE102950T1 (de) Verfahren zur herstellung von dipeptiden mit cterminalen nicht-proteinogenen aminosaeuren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee